Status:
UNKNOWN
PSLT Compared to Prostaglandin Analogue Eye Drops
Lead Sponsor:
Federal University of Rio Grande do Sul
Conditions:
Open Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This study aims to compare the efficacy of PSLT and the topical use of prostaglandin-like hypotensive eye drops in the treatment of ocular hypertensive or glaucomatous patients in decreasing intraocul...
Detailed Description
Patients with a diagnosis of ocular hypertension or bilateral glaucoma, naive or on treatment with up to two classes of hypotensive eye drops will be invited to participate in the study. These patien...
Eligibility Criteria
Inclusion
- Diagnosis of ocular hypertension (IOP ≥ 24 mmHg in both eyes) or diagnosis of open-angle glaucoma (POAG) in both eyes
- Proper visualization of angle structures and 360 degree open angles in both eyes
- No previous intraocular surgery with the exception of phacoemulsification with intraocular lens implantation
- No use of systemic medications known to increase IOP
Exclusion
- Patients using more than two glaucoma medications
- Evidence of any other eye disease that could affect IOP measurement
- Diagnosis of other types of glaucoma
- Patient with mean deviation (MD) less than -12 decibels (dB) on visual perimetry (severe disease)
- Patients with unilateral glaucoma
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05241938
Start Date
September 1 2021
End Date
December 20 2022
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil